Korean Medicine Based Herbal Drug Development Group, Herbal Medicine Research Division, Korea Institute of Oriental Medicine, 1672 Yuseongdae-ro, Yuseong-gu, Daejeon 305-811, Republic of Korea.
Evid Based Complement Alternat Med. 2013;2013:547653. doi: 10.1155/2013/547653. Epub 2013 Nov 13.
KIOM-79, a herbal mixture of parched Puerariae radix, gingered Magnoliae cortex, Glycyrrhizae radix, and Euphorbiae radix, has a strong inhibitory effect on advanced glycation end products (AGEs) formation. We investigated the beneficial effects of KIOM-79 on cardiac fibrosis in Zucker diabetic fatty (ZDF) rats. KIOM-79 (50 or 500 mg/kg/day) was orally administered for 13 weeks. AGEs formation and collagen expression in the myocardium were assessed by immunohistochemistry. The expression levels of the receptor for AGEs (RAGE), transforming growth factor- β 1 (TGF- β 1), collagen IV, fibronectin, urotensin II, and urotensin II receptor were examined in the myocardial tissue of ZDF rats. KIOM-79 treatment at 500 mg/kg inhibited the accumulation of AGEs, reduced RAGE mRNA and protein expression, and reduced the upregulation of cardiac fibrogenic factors, such as fibronectin and collagen IV, in heart of ZDF rats. Additionally, KIOM-79 ameliorated urotensin II/receptor gene expression in the cardiac tissue of ZDF rats. Our findings indicate that KIOM-79 diminishes cardiac fibrosis in ZDF rats by preventing AGEs accumulation and RAGE overexpression and by modulating the cardiac urotensin II/receptor pathway, which decreases the amount of profibrotic factors, such as TGF- β 1, fibronectin, and collagen in cardiac tissue.
KIOM-79 是一种药草混合物,由烤过的葛根、姜科植物肉桂、甘草和大戟组成,对晚期糖基化终产物 (AGEs) 的形成有很强的抑制作用。我们研究了 KIOM-79 对 Zucker 糖尿病肥胖 (ZDF) 大鼠心脏纤维化的有益作用。KIOM-79(50 或 500mg/kg/天)口服给药 13 周。通过免疫组织化学评估心肌中 AGEs 的形成和胶原蛋白表达。检查 ZDF 大鼠心肌组织中 AGEs 受体 (RAGE)、转化生长因子-β1 (TGF-β1)、胶原蛋白 IV、纤维连接蛋白、尿皮质素 II 和尿皮质素 II 受体的表达水平。500mg/kg 的 KIOM-79 治疗抑制了 AGEs 的积累,降低了 RAGE mRNA 和蛋白表达,并减少了心脏纤维化因子如纤维连接蛋白和胶原蛋白 IV 在 ZDF 大鼠心脏中的上调。此外,KIOM-79 改善了 ZDF 大鼠心脏组织中的尿皮质素 II/受体基因表达。我们的研究结果表明,KIOM-79 通过抑制 AGEs 积累和 RAGE 过表达以及调节心脏尿皮质素 II/受体途径来减轻 ZDF 大鼠的心脏纤维化,从而减少心脏组织中 TGF-β1、纤维连接蛋白和胶原蛋白等促纤维化因子的含量。